Benzamide derivatives as dual-action hypoglycemic agents that inhibit glycogen phosphorylase and activate glucokinase.
A series of benzamide derivatives which can simultaneously inhibit glycogen phosphorylase (GP) and activate glucokinase (GK) were prepared and evaluated. The structure-activity relationships (SAR) of these compounds were also presented. Among these, compounds 12, 13l, 13q, and 13v showed moderate activities towards both GK and GP. Compound 13h inhibited hLGP with an IC(50) of 8.95 microM and activated GK with an EC(50) of 1.87 microM. The possible binding modes of compounds 12, 13l, 13h, and 13q with GP and GK were also explored by molecular docking simulation.
Zhang
Lei
L
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, PR China.
Li
Honglin
H
Zhu
Qingzhang
Q
Liu
Jun
J
Chen
Ling
L
Leng
Ying
Y
Jiang
Hualiang
H
Liu
Hong
H
D001549:Benzamides / Q000737:chemistry / Q000494:pharmacology*; D004789:Enzyme Activation; D005941:Glucokinase / Q000378:metabolism*; D024981:Glycogen Phosphorylase / Q000037:antagonists & inhibitors*; D006801:Humans; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D001549:Benzamides; D007004:Hypoglycemic Agents; C037689:benzamide; D024981:Glycogen Phosphorylase; D005941:Glucokinase